LiVeritas Biosciences Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
15
- Latest Deal Type
-
Angel
- Latest Deal Amount
-
$170K
- Investors
-
3
LiVeritas Biosciences General Information
Description
Developer of artificial intelligence (AI)-powered scientific execution software designed to automate drug candidate characterization and protein-characterization workflows for regulated drug development. The company offers regulatory-grade artificial intelligence co-scientists that combine mass spectrometry workflows, scientific data, domain knowledge, validated processes, and traceable outputs, enabling biopharma scientists to execute complex analytical workflows more consistently and turn analytical data into trusted scientific intelligence.
Contact Information
Website
www.liveritas.bioCorporate Office
- 432 North Canal Street
- Suite 20
- South San Francisco, CA 94080
- United States
Corporate Office
- 432 North Canal Street
- Suite 20
- South San Francisco, CA 94080
- United States
LiVeritas Biosciences Timeline
LiVeritas Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Angel (individual) | 07-Aug-2026 | $170K | Completed | Generating Revenue | ||
| 7. Angel (individual) | 24-Dec-2025 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 01-Mar-2025 | Completed | Generating Revenue | |||
| 5. Angel (individual) | 04-Dec-2024 | Completed | Generating Revenue/Not Profitable | |||
| 4. Early Stage VC | 01-Apr-2022 | Completed | Startup | |||
| 3. Angel (individual) | 27-Dec-2021 | Completed | Startup | |||
| 2. Angel (individual) | 15-Nov-2020 | $40K | $90K | Completed | Startup | |
| 1. Accelerator/Incubator | 27-May-2020 | $50K | $50K | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
LiVeritas Biosciences Patents
LiVeritas Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250314628-A1 | Integrated platform for mass spectrometry | Pending | 07-Apr-2023 |
LiVeritas Biosciences Signals
LiVeritas Biosciences Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Kapwa Capital | Venture Capital | Minority | ||
| Dan Lok Ventures | Venture Capital | Minority | ||
| Expert DOJO | Venture Capital | Minority |
LiVeritas Biosciences FAQs
-
When was LiVeritas Biosciences founded?
LiVeritas Biosciences was founded in 2020.
-
Where is LiVeritas Biosciences headquartered?
LiVeritas Biosciences is headquartered in South San Francisco, CA.
-
What is the size of LiVeritas Biosciences?
LiVeritas Biosciences has 15 total employees.
-
What industry is LiVeritas Biosciences in?
LiVeritas Biosciences’s primary industry is Drug Discovery.
-
Is LiVeritas Biosciences a private or public company?
LiVeritas Biosciences is a Private company.
-
What is LiVeritas Biosciences’s current revenue?
The current revenue for LiVeritas Biosciences is .
-
How much funding has LiVeritas Biosciences raised over time?
LiVeritas Biosciences has raised $1.73M.
-
Who are LiVeritas Biosciences’s investors?
Kapwa Capital, Dan Lok Ventures, and Expert DOJO have invested in LiVeritas Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process